Food and agribusiness breakfast briefing: gene editing and novel foods

Gene editing and novel food technologies are moving from scientific possibility to commercial reality. From precision-bred crops and cultivated products to fermentation-derived ingredients and alternative proteins, businesses face a rapidly evolving regulatory landscape alongside increasing investor, retailer and consumer scrutiny. The position of marketing authorisations and the upcoming SPS, as well as recently published FSA guidance, has put another layer of complexity on the regulatory position for novel foods.

This session will explore what these developments mean in practice for food and agribusiness, helping attendees understand both the opportunities and the legal and regulatory considerations that accompany them.

If you require adjustments to take part in this webinar, please complete this requirements form.

Privacy notice:

^{By signing up Mills & Reeve will use the information you provide in accordance with our privacy policy. We may from time to time send you general updates by email or post that we think you will find of interest. This includes notification of upcoming events and updates or alerts containing relevant legal news. You can update your preferences at any time and will be able to easily unsubscribe from anything that you do not wish to receive.}

^{We may record and share the webinar on our YouTube channel, with delegates. By joining this webinar session, you acknowledge that this session will be recorded and understand that we will take reasonable steps to protect the privacy of participants such as capturing video only of the Mills & Reeve hosts, not capturing chat text and responding to questions anonymously. Further information is available in our privacy policy for online meetings and voice calls.}